According to diabetes news today, diabetes drug liraglutide could be better at promoting weight loss than orlistat and placebo, when combined with regular exercise and a healthy diet . The drug, the second in the incretin mimetic class, was launched after exenatide.
The diabetic drug was found to reduce weight more than placebo and orlistat over a 20 week period. Some 76% of those surveyed lost over 5% of body weight with a higher dose of liraglutide. This compared to some 30% on placebo and 44% on orlistat.
However, according to the study, more of those taking liraglutide had a greater rate of nausea and vomiting side effects, described by researchers as transient mild to moderate. The research team included professor Michael Lean from the University of Glasgow.
Diabetes drug better for weight loss
Tue, 27 Oct 2009
Recommended links
Diabetes and financeDiabetes and forum
Diabetes myLifestyle
Diabetes and charities
The Diet Plate to help control diabetes
Diabetes.co.uk Alert ID wristband
Diabetes drug may have pancreatitis risk
Denial over diabetes drug link
Heart risk not alleviated by diabetes drugs
Obesity increases diabetes drug bill
Med diet could delay diabetes drugs
Diabetes drug prescriptions must stop, study says
Stop prescribing diabetes drug, scientists say
New diabetes drug same price
Dementia drug risk amongst people with diabetes
Iron binding drug could help diabetes neuropathy
Diabetes drug cleared of cancer risk
Canada reviews diabetes drug
Diabetes drug review causes share climb
Sanofi maintain diabetes drug no riskier than insulin
Diabetes drug cleared for European market
Drug association encourages use of diabetes drug
Diabetes drug requires more research, FDA rule
Takeda diabetes drug setback
Diabetes drug reaching stage three trials
Study confirms how diabetes drugs can increase heart risk
New diabetes drug promising results
New Glaxo diabetes drug not overwhelming
Diabetes drug found to be more effective
Diabetes drug delayed for Europe
Diabetes drug could have cancer influence
Join us